Thrombocythemia Myelofibrosis
Showing 351 - 375 of 412
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in San Francisco, Winston-Salem (biological, drug,
Unknown status
- Chronic Myeloproliferative Disorders
- +6 more
- anti-thymocyte globulin
- +12 more
-
San Francisco, California
- +1 more
Jan 3, 2014
Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Cleveland (sargramostim, amifostine
Unknown status
- Chronic Myeloproliferative Disorders
- +7 more
- sargramostim
- +3 more
-
Cleveland, OhioCleveland Clinic Cancer Center
Dec 18, 2013
Primary Myelofibrosis Trial in Rochester (thalidomide, laboratory biomarker analysis)
Completed
- Primary Myelofibrosis
- thalidomide
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Oct 7, 2013
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +80 more
- imatinib mesylate
- pharmacological study
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 6, 2013
Cancer Trial in Chandler (Fentanyl sublingual spray, Placebo)
Completed
- Cancer
- Fentanyl sublingual spray
- Placebo
-
Chandler, ArizonaInSys Therapeutics, Incorporated
Jan 14, 2014
Primary Myelofibrosis, Fibrosis, Bone Marrow Trial in Scottsdale, Palo Alto, Houston (IPI-926)
Completed
- Primary Myelofibrosis
- Fibrosis, Bone Marrow
-
Scottsdale, Arizona
- +2 more
Nov 14, 2012
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab ozogamicin)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Decitabine
- Gemtuzumab ozogamicin
-
Houston, TexasUT MD Anderson Cancer Center
Sep 3, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (pyroxamide)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 4, 2013
Cancer Trial in Cleveland (forodesine HCl)
Completed
- Cancer
- forodesine hydrochloride
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center
May 29, 2013
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI
Terminated
- Chronic Myeloproliferative Disorders
- +2 more
- cyclophosphamide
- +15 more
-
Bethesda, MarylandNIH - Warren Grant Magnuson Clinical Center
Apr 30, 2013
JAK-STAT Signalling Pathway in Familial Myeloproliferative
Completed
- Myeloproliferative Disorders
- Blood samples and buccal swabs
-
Paris, FranceDepartment of Hematology, Hospital Saint Antoine
Mar 7, 2013
Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)
Withdrawn
- Myeloproliferative Disorders
- +7 more
- aprepitant
- ondansetron hydrochloride
- (no location specified)
Mar 29, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Zion (carboplatin, docetaxel, ifosfamide)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- carboplatin
- +5 more
-
Zion, IllinoisMidwestern Regional Medical Center
Mar 25, 2013
Studying Fentanyl in Patients With Cancer
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- fentanyl citrate
- pharmacological study
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013
Myelofibrosis Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))
Completed
- Myelofibrosis
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +6 more
Aug 16, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte, Los Angeles, Sacramento (decitabine)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
-
Duarte, California
- +3 more
Feb 13, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Feb 8, 2013
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Houston (decitabine, romidepsin)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
-
Houston, TexasM.D. Anderson Cancer Center at University of Texas
Feb 8, 2013
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Seoul (donor natural killer cell infusion)
Completed
- Brain and Central Nervous System Tumors
- +8 more
- donor natural killer cell infusion
-
Seoul, Korea, Republic ofUniversity of Ulsan, Asan Medical Center
Feb 18, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Columbus (recombinant interferon alfa, recombinant
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- recombinant interferon alfa
- recombinant interleukin-12
-
Columbus, OhioArthur G. James Cancer Hospital - Ohio State University
Jan 31, 2013
Chronic Myeloproliferative Disorders, Infection, Leukemia Trial (Edetate Calcium Disodium, Ethanol,
Withdrawn
- Chronic Myeloproliferative Disorders
- +8 more
- Edetate Calcium Disodium
- +3 more
- (no location specified)
Feb 13, 2013
Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in New York (St. John's wort)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- St. John's wort
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 17, 2013
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Tampa (biological, drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +9 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 10, 2012
Cancer Trial in New York (caspofungin acetate, liposomal amphotericin B)
Completed
- Cancer
- caspofungin acetate
- liposomal amphotericin B
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 17, 2013